JISCMail - EVIDENCE-BASED-HEALTH Archives

Email discussion lists for the UK Education and Research communities

Subscriber's Corner

Email Lists

EVIDENCE-BASED-HEALTH Archives

November 2018

View:

Show Author | Hide Author

		LISTSERV Archives
		EVIDENCE-BASED-HEALTH Home

Options

Subscribe or Unsubscribe

Get Password

Subject	From	Date	Size
Re: LDL and mortality (and use of statins)	Owen Dempsey	Thu, 1 Nov 2018 11:28:16 +0000	1984 lines
New Postgraduate Certificate in Teaching Evidence-Based Health Care	University of Oxford CPD Centre	Thu, 1 Nov 2018 12:00:21 +0000	609 lines
Re: LDL and mortality (and use of statins)	McCormack, James	Thu, 1 Nov 2018 14:41:50 +0000	1760 lines
Screening.	Glen Burgoyne	Thu, 1 Nov 2018 15:01:57 +0000	49 lines
Re: LDL and mortality (and use of statins)	Evelyn Cornelissen	Thu, 1 Nov 2018 08:47:28 -0700	2280 lines
Re: LDL and mortality (and use of statins)	Rod Jackson	Thu, 1 Nov 2018 16:45:48 +0000	1787 lines
Re: LDL and mortality (and use of statins)	Rod Jackson	Thu, 1 Nov 2018 17:00:16 +0000	1607 lines
Re: LDL and mortality (and use of statins)	Djulbegovic, Benjamin	Thu, 1 Nov 2018 17:27:47 +0000	1750 lines
Re: LDL and mortality (and use of statins)	Juan Gérvas	Thu, 1 Nov 2018 18:47:45 +0100	2890 lines
Re: LDL and mortality (and use of statins)	Rod Jackson	Thu, 1 Nov 2018 20:14:00 +0000	1905 lines
Re: LDL and mortality (and use of statins)	Juan Gérvas	Thu, 1 Nov 2018 22:01:33 +0100	3209 lines
Re: LDL and mortality (and use of statins)	McCormack, James	Thu, 1 Nov 2018 21:09:06 +0000	2235 lines
Re: LDL and mortality (and use of statins)	Owen Dempsey	Thu, 1 Nov 2018 21:10:49 +0000	2917 lines
Re: LDL and mortality (and use of statins)	Juan Gérvas	Thu, 1 Nov 2018 22:20:08 +0100	3008 lines
Re: LDL and mortality (and use of statins)	Rod Jackson	Thu, 1 Nov 2018 21:21:32 +0000	1997 lines
Re: LDL and mortality (and use of statins)	McCormack, James	Thu, 1 Nov 2018 21:34:45 +0000	2107 lines
Re: LDL and mortality (and use of statins)	Juan Gérvas	Thu, 1 Nov 2018 22:47:40 +0100	3206 lines
Re: LDL and mortality (and use of statins)	Neal Maskrey	Thu, 1 Nov 2018 17:57:17 -0400	3210 lines
Re: LDL and mortality (and use of statins)	Rod Jackson	Thu, 1 Nov 2018 22:32:26 +0000	2599 lines
Re: LDL and mortality (and use of statins)	McCormack, James	Thu, 1 Nov 2018 22:59:21 +0000	2203 lines
Re: LDL and mortality (and use of statins)	Mohammed T. Ansari	Thu, 1 Nov 2018 19:05:27 -0400	3384 lines
Re: LDL and mortality (and use of statins)	McCormack, James	Thu, 1 Nov 2018 23:15:46 +0000	2283 lines
Re: LDL and mortality (and use of statins)	Rod Jackson	Thu, 1 Nov 2018 23:19:33 +0000	2883 lines
Re: LDL and mortality (and use of statins)	Lyndal Trevena	Thu, 1 Nov 2018 23:23:21 +0000	2764 lines
Re: LDL and mortality (and use of statins)	Djulbegovic, Benjamin	Thu, 1 Nov 2018 23:30:27 +0000	2529 lines
Re: LDL and mortality (and use of statins)	Mohammed T. Ansari	Thu, 1 Nov 2018 19:32:37 -0400	3516 lines
Re: LDL and mortality (and use of statins)	Neal Maskrey	Thu, 1 Nov 2018 20:24:29 -0400	3308 lines
Re: LDL and mortality (and use of statins)	McCormack, James	Fri, 2 Nov 2018 00:53:40 +0000	3293 lines
Re: LDL and mortality (and use of statins)	Mohammed T. Ansari	Thu, 1 Nov 2018 21:07:18 -0400	4388 lines
Re: LDL and mortality (and use of statins)	McCormack, James	Fri, 2 Nov 2018 02:15:50 +0000	3046 lines
Re: LDL and mortality (and use of statins)	Mohammed T. Ansari	Thu, 1 Nov 2018 22:23:09 -0400	5101 lines
Re: LDL and mortality (and use of statins)	Neal Maskrey	Thu, 1 Nov 2018 23:14:44 -0400	4686 lines
Re: LDL and mortality (and use of statins)	McCormack, James	Fri, 2 Nov 2018 04:22:55 +0000	3913 lines
Re: LDL and mortality (and use of statins)	Michael Power	Fri, 2 Nov 2018 06:06:31 +0000	5570 lines
Re: LDL and mortality (and use of statins)	Owen Dempsey	Fri, 2 Nov 2018 11:41:32 +0000	5895 lines
Please read apropos recent discussion of screening	Donald E. Stanley	Fri, 2 Nov 2018 15:05:08 +0000	30 lines
Re: LDL and mortality (and use of statins)	Djulbegovic, Benjamin	Fri, 2 Nov 2018 15:31:37 +0000	5933 lines
Re: LDL and mortality (and use of statins)	McCormack, James	Fri, 2 Nov 2018 15:40:16 +0000	4304 lines
Re: LDL and mortality (and use of statins)	McCormack, James	Fri, 2 Nov 2018 15:49:16 +0000	4389 lines
New website for Teachers of EBHC	Douglas Badenoch	Fri, 2 Nov 2018 15:52:53 +0000	142 lines
Re: LDL and mortality (and use of statins)	Juan Gérvas	Fri, 2 Nov 2018 17:49:45 +0100	6372 lines
Re: LDL and mortality (and use of statins)	Huw Llewelyn [hul2]	Fri, 2 Nov 2018 16:49:56 +0000	4466 lines
Re: LDL and mortality (and use of statins)	Djulbegovic, Benjamin	Fri, 2 Nov 2018 17:42:53 +0000	3580 lines
Re: LDL and mortality (and use of statins)	Owen Dempsey	Fri, 2 Nov 2018 21:34:33 +0000	6312 lines
Re: LDL and mortality (and use of statins)	Djulbegovic, Benjamin	Sat, 3 Nov 2018 01:01:10 +0000	6127 lines
Re: LDL and mortality (and use of statins)	Neal Maskrey	Fri, 2 Nov 2018 21:29:37 -0400	7279 lines
Re: LDL and mortality (and use of statins)	Glen Burgoyne	Sat, 3 Nov 2018 02:47:23 +0000	4799 lines
Re: LDL and mortality (and use of statins)	Kumara Mendis	Sat, 3 Nov 2018 10:17:48 +0530	7103 lines
Re: LDL and mortality (and use of statins)	Rod Jackson	Sat, 3 Nov 2018 07:04:25 +0000	1219 lines
Re: EBM or GFBM "GutFeelingBasedMedicine"?	Wouter Havinga	Sat, 3 Nov 2018 08:04:29 +0000	94 lines
Re: LDL and mortality (and use of statins)	Vasiliy Vlassov	Sat, 3 Nov 2018 13:15:43 +0300	68 lines
Re: LDL and mortality (and use of statins)	Per Olav Vandvik	Sat, 3 Nov 2018 11:28:54 +0100	6562 lines
Re: LDL and mortality (and use of statins)	Owen Dempsey	Sat, 3 Nov 2018 11:35:02 +0000	7391 lines
Re: LDL and mortality (and use of statins)	Vasiliy Vlassov	Sat, 3 Nov 2018 15:34:39 +0300	87 lines
Re: EBM or GFBM "GutFeelingBasedMedicine"?	David Richard Leslie Cawthorpe	Sat, 3 Nov 2018 15:14:23 +0000	332 lines
Should testing of asymptomatic patients and screening be abandoned?	Djulbegovic, Benjamin	Sat, 3 Nov 2018 18:02:56 +0000	146 lines
Re: LDL and mortality (and use of statins)	Owen Dempsey	Sat, 3 Nov 2018 21:08:45 +0000	301 lines
Re: Should testing of asymptomatic patients and screening be abandoned?	Rod Jackson	Sat, 3 Nov 2018 21:19:01 +0000	141 lines
Re: Should testing of asymptomatic patients and screening be abandoned?	Owen Dempsey	Sat, 3 Nov 2018 21:34:33 +0000	444 lines
Re: LDL and mortality (and use of statins)	Mohammed T. Ansari	Sat, 3 Nov 2018 17:55:47 -0400	2132 lines
Re: LDL and mortality (and use of statins)	McCormack, James	Sat, 3 Nov 2018 22:36:48 +0000	1470 lines
Re: LDL and mortality (and use of statins)	Mohammed T. Ansari	Sat, 3 Nov 2018 19:02:23 -0400	2285 lines
Re: LDL and mortality (and use of statins)	McCormack, James	Sat, 3 Nov 2018 23:30:50 +0000	1597 lines
Re: LDL and mortality (and use of statins)	Kumara Mendis	Sun, 4 Nov 2018 06:36:58 +0530	2553 lines
Re: LDL and mortality (and use of statins)	Mohammed T. Ansari	Sat, 3 Nov 2018 23:55:19 -0400	2469 lines
Urgent 24 hours: Please sign this letter to the Danish Minister of Health against the dismissal of Peter Gotzsche from his job at Rigshospitalet in Copenhagen	Juan Gérvas	Sun, 4 Nov 2018 18:34:14 +0100	257 lines
Re: LDL and mortality (and use of statins)	Rod Jackson	Sun, 4 Nov 2018 20:04:36 +0000	1425 lines
Re: Should testing of asymptomatic patients and screening be abandoned?	Rod Jackson	Sun, 4 Nov 2018 20:09:10 +0000	136 lines
Re: Urgent 24 hours: Please sign this letter to the Danish Minister of Health against the dismissal of Peter Gotzsche from his job at Rigshospitalet in Copenhagen	Juan Gérvas	Sun, 4 Nov 2018 22:41:59 +0100	367 lines
Re: LDL and mortality (and use of statins)	Mohammed T. Ansari	Sun, 4 Nov 2018 17:43:41 -0500	2451 lines
Primary care risk prevention in a nutshell	McCormack, James	Mon, 5 Nov 2018 02:04:59 +0000	49 lines
Re: Primary care risk prevention in a nutshell	Michael Power	Mon, 5 Nov 2018 08:09:09 +0000	221 lines
Re: Should testing of asymptomatic patients and screening be abandoned?	Kelleher, Kevin	Mon, 5 Nov 2018 09:21:36 +0000	178 lines
Re: Primary care risk prevention in a nutshell	Owen Dempsey	Mon, 5 Nov 2018 13:07:05 +0000	270 lines
Re: Primary care risk prevention in a nutshell	McCormack, James	Mon, 5 Nov 2018 15:25:18 +0000	223 lines
Re: Primary care risk prevention in a nutshell	McCormack, James	Mon, 5 Nov 2018 15:39:55 +0000	374 lines
Reduced Salt Intake for Heart Failure A Systematic Review	David Nunan	Mon, 5 Nov 2018 16:18:43 +0000	207 lines
Re: Reduced Salt Intake for Heart Failure A Systematic Review	Rakesh Biswas	Tue, 6 Nov 2018 09:03:51 +0530	272 lines
Diversity in academy, and leadership	Juan Gérvas	Tue, 6 Nov 2018 11:09:03 +0100	418 lines
How to conduct a high-quality original study on a prognostic research topic	Yao, Xiaomei	Tue, 6 Nov 2018 18:43:10 +0000	343 lines
Bye Bye Peter Gøtzsche. We need another Cochrane	Juan Gérvas	Tue, 6 Nov 2018 22:17:46 +0100	56 lines
Re: How to conduct a high-quality original study on a prognostic research topic	Rod Jackson	Wed, 7 Nov 2018 01:50:18 +0000	391 lines
Re: How to conduct a high-quality original study on a prognostic research topic	Yao, Xiaomei	Wed, 7 Nov 2018 05:12:17 +0000	473 lines
Tutorial for Reproducible Search and Session on Automation of Systematic Reviews	Farhad Shokraneh	Wed, 7 Nov 2018 16:09:40 +0000	219 lines
Re: Primary care risk prevention in a nutshell	Owen Dempsey	Wed, 7 Nov 2018 17:13:49 +0000	713 lines
Re: Primary care risk prevention in a nutshell	Djulbegovic, Benjamin	Wed, 7 Nov 2018 17:42:31 +0000	775 lines
Re: Primary care risk prevention in a nutshell	Jim Walker	Wed, 7 Nov 2018 13:25:15 -0500	1173 lines
Re: Primary care risk prevention in a nutshell	Amy Price	Wed, 7 Nov 2018 18:52:20 +0000	900 lines
Re: Primary care risk prevention in a nutshell	Rod Jackson	Wed, 7 Nov 2018 19:26:04 +0000	938 lines
Re: Primary care risk prevention in a nutshell	McCormack, James	Wed, 7 Nov 2018 20:03:46 +0000	1375 lines
Re: Primary care risk prevention in a nutshell	Ash Paul	Wed, 7 Nov 2018 20:09:45 +0000	1459 lines
Re: Primary care risk prevention in a nutshell	[log in to unmask]	Wed, 7 Nov 2018 20:26:06 +0000	1635 lines
Re: Primary care risk prevention in a nutshell	Amy Price	Wed, 7 Nov 2018 20:40:57 +0000	1121 lines
Re: Primary care risk prevention in a nutshell	Amy Price	Wed, 7 Nov 2018 20:44:45 +0000	1167 lines
Re: Primary care risk prevention in a nutshell	Neal Maskrey	Wed, 7 Nov 2018 17:30:47 -0400	1855 lines
Business Analytics and AI workshops live and online	Geoffrey Hubona	Thu, 8 Nov 2018 09:58:27 -0700	28 lines
Name that study! Do we need a new category?	Kev Hopayian	Fri, 9 Nov 2018 09:24:58 +0000	1199 lines
Job vacancy in Abersdeen	BROWN, Juliet (NHS HEALTHCARE IMPROVEMENT SCOTLAND)	Fri, 9 Nov 2018 09:44:54 +0000	79 lines
Job vacancy - Lead Health Services Researcher	Karen Macpherson	Fri, 9 Nov 2018 15:51:28 +0000	67 lines
Re: BMJ News reporting 14% increased risk of ACEI associated lung cancer	Yao, Xiaomei	Fri, 9 Nov 2018 17:37:51 +0000	635 lines
Re: Name that study! Do we need a new category?	Dan Mayer	Fri, 9 Nov 2018 16:17:30 -0500	264 lines
Re: Name that study! Do we need a new category?	Birnbaum, David	Fri, 9 Nov 2018 22:07:11 +0000	302 lines
Re: Name that study! Do we need a new category?	Michael Power	Fri, 9 Nov 2018 22:33:22 +0000	1236 lines
Re: Name that study! Do we need a new category?	Pennington, Andy	Fri, 9 Nov 2018 23:58:20 +0000	882 lines
Crisis Cochrane. Peter C Gøtzsche's voice	Juan Gérvas	Sat, 10 Nov 2018 16:01:45 +0100	54 lines
Re: Name that study! Do we need a new category?	Rod Jackson	Sat, 10 Nov 2018 20:37:52 +0000	915 lines
Re: Primary care risk prevention in a nutshell	Owen Dempsey	Sat, 10 Nov 2018 22:02:22 +0000	2056 lines
Re: How a medical student can learn critical appraisal skills when medical school don't teach??	avinash kumar gupta	Sun, 11 Nov 2018 11:09:50 +0545	1841 lines
Re: Name that study! Do we need a new category?	Kev Hopayian	Sun, 11 Nov 2018 09:43:44 +0000	354 lines
Re: Name that study! Do we need a new category?	Kev Hopayian	Sun, 11 Nov 2018 09:57:53 +0000	334 lines
Difference in difference estimation	Kev Hopayian	Sun, 11 Nov 2018 11:03:43 +0000	193 lines
Re: Difference in difference estimation	Pennington, Andy	Sun, 11 Nov 2018 16:15:51 +0000	221 lines
examples of ethical censoring	Vasiliy Vlassov	Sun, 11 Nov 2018 21:02:08 +0300	34 lines
Re: Name that study! Do we need a new category?	Dan Mayer	Sun, 11 Nov 2018 13:44:24 -0500	329 lines
Re: Name that study! Do we need a new category?	Federico Barbani USL	Sun, 11 Nov 2018 19:50:33 +0100	263 lines
Re: Name that study! Do we need a new category?	Djulbegovic, Benjamin	Sun, 11 Nov 2018 19:32:23 +0000	534 lines
Re: Name that study! Do we need a new category?	Federico Barbani	Sun, 11 Nov 2018 22:31:02 +0100	656 lines
Re: How a medical student can learn critical appraisal skills when medical school don't teach??	Rod Jackson	Mon, 12 Nov 2018 03:34:19 +0000	1343 lines
Re: Name that study! Do we need a new category?	Kev Hopayian	Mon, 12 Nov 2018 10:48:16 +0000	789 lines
Re: Name that study! Do we need a new category?	Kev Hopayian	Mon, 12 Nov 2018 11:40:12 +0000	425 lines
Why is the fatality rate so low?	Guylene Theriault	Mon, 12 Nov 2018 12:58:19 +0000	149 lines
Re: Name that study! Do we need a new category?	[log in to unmask]	Mon, 12 Nov 2018 14:01:15 +0000	600 lines
Re: Name that study! Do we need a new category?	Djulbegovic, Benjamin	Mon, 12 Nov 2018 14:39:27 +0000	855 lines
Re: examples of ethical censoring	Djulbegovic, Benjamin	Mon, 12 Nov 2018 15:07:57 +0000	80 lines
How Cochrane is doing pharma a good turn	Tom Jefferson	Mon, 12 Nov 2018 16:16:36 +0100	99 lines
Re: Name that study! Do we need a new category?	Michael Power	Mon, 12 Nov 2018 16:34:05 +0000	1130 lines
Re: Name that study! Do we need a new category?	David Nunan	Mon, 12 Nov 2018 16:57:24 +0000	763 lines
Re: Name that study! Do we need a new category?	Janet Martin	Mon, 12 Nov 2018 17:13:54 +0000	864 lines
Re: Name that study! Do we need a new category?	Dr. Abdelhamid Attia	Mon, 12 Nov 2018 20:06:39 +0200	365 lines
Re: How Cochrane is doing pharma a good turn	Juan Gérvas	Mon, 12 Nov 2018 22:53:20 +0100	180 lines
REMINDER: Mixed Methods Systematic Review and Searching the Evidence Base Courses - Early bird rate closing soon!	Judy Wright	Tue, 13 Nov 2018 11:05:15 +0000	379 lines
Re: Name that study! Do we need a new category?	Kev Hopayian	Tue, 13 Nov 2018 17:13:38 +0000	403 lines
Re: Name that study! Do we need a new category?	Kev Hopayian	Tue, 13 Nov 2018 17:43:20 +0000	1011 lines
Re: Name that study! Do we need a new category?	Djulbegovic, Benjamin	Tue, 13 Nov 2018 20:34:43 +0000	1015 lines
Re: How a medical student can learn critical appraisal skills when medical school don't teach??	Chris Del Mar	Wed, 14 Nov 2018 06:19:36 +0000	1717 lines
Real-World Evidence is here to stay	Ernesto Barrera	Thu, 15 Nov 2018 09:58:47 +0100	73 lines
Introduction to Statistics for Health Care Research, University of Oxford	University of Oxford CPD Centre	Thu, 15 Nov 2018 11:44:50 +0000	1107 lines
Cochrane Crisis. John Ioannidis	Juan Gérvas	Sun, 18 Nov 2018 13:44:04 +0100	211 lines
Re: Cochrane Crisis. John Ioannidis	Juan Gérvas	Sun, 18 Nov 2018 14:09:44 +0100	250 lines
Re: Cochrane Crisis. John Ioannidis	Juan Gérvas	Tue, 20 Nov 2018 08:55:01 +0100	305 lines
Job Vacancy - Band 6 - Clinical Librarian	WILLIAMS, Christine (DARTFORD AND GRAVESHAM NHS TRUST)	Thu, 22 Nov 2018 14:29:09 +0000	456 lines
Please help - is there a reputable journal that would publish a proper critique of the latest PURE study results?	Rod Jackson	Sat, 24 Nov 2018 02:31:36 +0000	57 lines
Re: Please help - is there a reputable journal that would publish a proper critique of the latest PURE study results?	Jim Mann	Sat, 24 Nov 2018 03:37:45 +0000	98 lines
Re: Please help - is there a reputable journal that would publish a proper critique of the latest PURE study results?	Carl Heneghan	Sat, 24 Nov 2018 11:54:57 +0000	84 lines
Re: Please help - is there a reputable journal that would publish a proper critique of the latest PURE study results?	David Nunan	Sat, 24 Nov 2018 15:03:01 +0000	82 lines
Re: Please help - is there a reputable journal that would publish a proper critique of the latest PURE study results?	McCormack, James	Sat, 24 Nov 2018 18:02:10 +0000	113 lines
Re: Please help me develop a collective critique of the latest PURE study results which we can publish in BMJ EBM	Rod Jackson	Sat, 24 Nov 2018 21:31:15 +0000	284 lines
Medical devices. #implantfiles	Juan Gérvas	Sun, 25 Nov 2018 18:28:50 +0100	83 lines
Re: Medical devices. #implantfiles	Juan Gérvas	Sun, 25 Nov 2018 23:14:03 +0100	112 lines
Early Bird Final REMINDER: Mixed Methods Systematic Review and Searching the Evidence Base Courses	Judy Wright	Mon, 26 Nov 2018 15:37:11 +0000	380 lines
Job Vacancy - Information Specialist, Leeds Institute of Health Sciences, University of Leeds	Judy Wright	Thu, 29 Nov 2018 14:13:04 +0000	205 lines

EVIDENCE-BASED-HEALTH Archives

November 2018

Options

Subject

From

Date

Size

JiscMail Tools

RSS Feeds and Sharing

Search Archives

Archives